On a similar note, a high CD8+ effector T-cell-to-Treg cell ratio, rather than the absolute number of each, has been suggested as an independent predictor of survival for patients affected by ovarian carcinoma [14] as well as breast cancer [28]. This evidence concerns the gene CD8A and breast cancer.